Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer

Published:2016-05-29 Issue:9 Volume:23 Page:3350-3357
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Yuan Yueling¹,Cai Tiange²,Xia Xi¹,Zhang Ronghua¹,Chiba Peter³,Cai Yu¹⁴

Affiliation:

1. College of Pharmacy, Jinan University, Guangzhou, P. R. China,

2. College of Life Science, Liaoning University, Shenyang, P. R. China,

3. Medical University of Vienna, Vienna, Austria, and

4. Cancer Research Institute of Jinan University, Guangzhou, P. R. China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2016.1178825

Reference97 articles.

1. Pluronics and MDR Reversal: An Update

2. Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers

3. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion

4. Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in dendrimer-based drug delivery for combinatorial cancer therapy;Journal of Drug Delivery Science and Technology;2024-08

2. Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer;Frontiers in Oncology;2024-05-02

3. Green Extracts with Metal-based Nanoparticles for Treating Inflammatory Diseases: A Review;Current Drug Delivery;2024-05

4. Nanoplatform based on carbon nanoparticles loaded with doxorubicin enhances apoptosis by generating reactive oxygen species for effective cancer therapy;Oncology Letters;2024-04-30

5. Biosynthesized metallic nanoparticles: A new era in cancer therapy;Archiv der Pharmazie;2024-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3